A recent probe report on the overheated medicine market in Bangladesh has recommended implementing full government control over lifesaving drug prices and promoting the low-duty import of necessary raw materials. The report, comprising 17-point recommendations from a government intelligence agency, aims to address the escalating prices of medicines. Key suggestions include prioritizing the import of raw materials, reducing import hurdles faced by drug-makers during LC opening with banks, and streamlining the process for other supplies. The report also calls for intensified vigilance by the Directorate General of Drug Administration, prevention of unilateral price increases by pharmaceutical companies, and empowerment of the government’s drug administration to fix logical prices for a broader range of generics. These measures, if implemented, could help ensure affordable access to essential medicines for the people of Bangladesh. The report has been presented to the Prime Minister’s Office for further action and consideration.
Report suggests full government control over lifesaving drug price
Industry: Healthcare & Pharma, Pharma
Source for more details: